Evidence map›Paper›PMID 41061054›Full record

ArticleScience advances2025

Endogenous p21 levels protect genomic stability by suppressing both excess and restrained nascent DNA syntheses.

Nicolás L Calzetta, Sabrina F Mansilla, Candelaria Mares Ahlers, Agostina P Bertolin, Lilen I Caimi, Sofía Venerus Arbilla, Jingkun Zeng, Lisa Wiesmüller, Vanesa Gottifredi

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicolás L CalzettaFundación Instituto Leloir (IIBBA-CONICET), Buenos Aires, Argentina.ORCID 0000-0002-5790-0515
Sabrina F MansillaFundación Instituto Leloir (IIBBA-CONICET), Buenos Aires, Argentina.ORCID 0000-0001-7752-3377
Candelaria Mares AhlersFundación Instituto Leloir (IIBBA-CONICET), Buenos Aires, Argentina.ORCID 0009-0006-6772-0696
Agostina P BertolinFrancis Crick Institute, London, UK.
Lilen I CaimiFundación Instituto Leloir (IIBBA-CONICET), Buenos Aires, Argentina.ORCID 0009-0008-2769-0714
Sofía Venerus ArbillaFundación Instituto Leloir (IIBBA-CONICET), Buenos Aires, Argentina.ORCID 0000-0003-2826-7615
Jingkun ZengFrancis Crick Institute, London, UK.ORCID 0000-0002-1709-319X
Lisa WiesmüllerDepartment of Obstetrics and Gynecology, Ulm University, Ulm, Germany.ORCID 0000-0002-2397-5041
Vanesa GottifrediFundación Instituto Leloir (IIBBA-CONICET), Buenos Aires, Argentina.ORCID 0000-0001-9656-5951

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rate of DNA synthesis is crucial for full DNA duplication. We report a key role of p21 in controlling this rate. During normal replication, p21 promotes nascent DNA synthesis alongside the DNA polymerase iota (Pol ι)/p53 complex. When p21 is down-regulated but detectable, nascent DNA tracks are longer and discontinuous and rely on primase and DNA polymerase (PrimPol). With the complete elimination of p21, nascent DNA tracks become shorter and continuous and depend on Pol kappa (κ). Endogenous p21 levels are critical for genomic stability, as both PrimPol- and Pol κ-mediated syntheses can induce chromosomal instability. The residual expression of p21 in p53-null cells influences the involvement of PrimPol or Pol κ in nascent DNA synthesis and subsequent chromosomal instability. Our results demonstrate that endogenous levels of p21 in cycling cells, insufficient for cyclin-dependent kinase inhibition, prevent genomic instability through proliferating cell nuclear antigen binding (PCNA), limiting PrimPol and Pol κ's role in nascent DNA synthesis.

Indexed as

Cyclin-Dependent Kinase Inhibitor p21DNADNA ReplicationGenomic InstabilityDNA-Directed DNA PolymeraseDNA Polymerase iotaDNA PrimaseHumansMultifunctional EnzymesProliferating Cell Nuclear AntigenTumor Suppressor Protein p53Y-Family DNA PolymerasesCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21DNADNA-Directed DNA PolymeraseDNA Polymerase iotaDNA PrimaseMultifunctional EnzymesPOLK protein, humanPrimPol protein, humanProliferating Cell Nuclear AntigenTumor Suppressor Protein p53Y-Family DNA Polymerases

Identifiers

PMID41061054
PMCPMC12506965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.